BPH - Benign Prostatic Enlargement - Results from #2720

Treatment of benign prostatic hyperplasia by Prostiva(®): About a series of 76 cases - Abstract September 26, 2011

Overview of prostate anatomy, histology, and pathology - Abstract September 26, 2011

Survey of overactive bladder symptoms influencing bother before and after treatment with tamsulosin hydrochloride in Japanese patients with benign prostatic hyperplasia - Abstract September 23, 2011

Systematic review of surgical treatments for benign prostatic hyperplasia and presentation of an approach to investigate therapeutic equivalence (non-inferiority) - Abstract September 23, 2011

Long-term results of a randomized trial comparing holmium laser enucleation of the prostate and transurethral resection of the prostate: Results at 7 years - Abstract September 22, 2011

Efficacy and safety of tadalafil once daily in the treatment of men with lower urinary tract symptoms suggestive of benign prostatic hyperplasia: Results of an international randomized, double-blind, placebo-controlled trial - Abstract September 20, 2011

A multiinstitutional study of the effects of medical therapy for lower urinary symptoms on the perioperative outcomes of holmium laser enucleation of the prostate - Abstract September 19, 2011

Combined tadalafil and {alpha}-blocker therapy for benign prostatic hyperplasia in patients with erectile dysfunction: A multicenter, prospective study - Abstract September 16, 2011

Efficacy and tolerability of tamsulosin 0.4 mg in patients with symptomatic benign prostatic hyperplasia - Abstract September 15, 2011

Up-regulation of α(1a) and α(1d)-adrenoceptors in the prostate by administration of subtype selective α(1)-adrenoceptor antagonist tamsulosin in patients with benign prostatic hyperplasia - Abstract September 13, 2011

Assessment of lower urinary tract symptoms in men by international prostate symptom score and core lower urinary tract symptom score - Abstract September 13, 2011

Significance of histological prostatitis in patients with urinary retention and underlying benign prostatic hyperplasia or adenocarcinoma of the prostate - Abstract September 12, 2011

Merit Medical sponsors educational forum on new multidisciplinary treatment for benign prostatic hyperplasia September 12, 2011

Prevention and management of TURP-related hemorrhage - Abstract September 9, 2011

Temporary placement of covered retrievable expandable nitinol stents with barbs in high-risk surgical patients with benign prostatic hyperplasia: Work in progress - Abstract September 9, 2011

Blood loss comparison during trans-urethral resection of prostate and high power GreenLight(™) laser therapy using isotopic measure of red blood cells volume - Abstract September 8, 2011

Lost to follow-up in high level evidence-based studies related to the surgical management of lower urinary tract symptoms secondary to benign prostatic enlargement: Does it matter? - Abstract September 7, 2011

Medical treatment of benign prostatic hyperplasia - Abstract September 6, 2011

What do I tell patients about saw palmetto for benign prostatic hyperplasia? - Abstract September 5, 2011

Effects of 100 and 300 units of onabotulinum toxin A on lower urinary tract symptoms of benign prostatic hyperplasia: A phase II randomized clinical trial - Abstract September 2, 2011

Page 137 of 142